SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

More premies driving neonatal market in Europe: report Despite being "saturated" the European infant care solutions market is growing due to a rise in preterm births

MR-guided focused ultrasound is a possible “cost-effective strategy” for uterine fibroid treatment OHTAC recommends the procedure based on economic analysis

Rayence gets FDA nod for RU-3000 Digital Universal Radiography System First U-arm marketed by Rayence in U.S.

Imaging informatics accelerates change-agent role in ACA transition How imaging informatics quickly transformed the change-agent role in ACA translation

Study finds correlation between gun wound patients and stock market performance Hospitals may now have a new incentive for monitoring national economics

Los Alamos National Laboratory creates ultra-low-field MRI for developing countries and battlefields Radio signals 50 miles away can interfere with these detectors

Siemens' tomosynthesis add-on for mammography platform scores FDA approval Provides a wide angle 50 degree angulation arc

IBA's ProteusPLUS will be first proton therapy system in the Netherlands The two-gantry configuration will be installed in partnership with University Medical Center Groningen

Health IT Viewpoints Industry experts share advice and discuss the challenges

RFID – a passive solution How RFID is a low cost alternative to most RTLS infrastructures

Hologic wraps up $3.8 billion Gen-Probe buy

by Brendon Nafziger , DOTmed News Associate Editor
Hologic said Wednesday that it wrapped up its nearly $3.8 billion cash purchase of molecular diagnostics company Gen-Probe Inc., in line with the company's earlier projections.

On an earnings call this week, the publicly traded women's health medical device company indicated that it expected the deal, first announced in April, to finish by Aug. 1.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your probe with the same precision and care you provide to your patients. Call us at 1-844-MVS-5100 (1-844-687-5100) or visit www.ri.bayer.com



Gen-Probe, based in San Diego, makes tests for STDs and the West Nile Virus, among other conditions.

Gen-Probe's shareholders voted to approve the transaction on Tuesday. Shareholders will receive $82.75 in cash for each share.

Hologic expects the deal to add 20 cents to its adjusted earnings per share for the next fiscal year. The Bedford, Mass.-based company also hopes to realize $75 million in "cost synergies" over the next three years.

This week, while announcing third quarter financial results, Hologic also revealed that it was nearly halfway to its sales goal for its 3-D mammography system, the first of its kind cleared for sale in the United States.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED